Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Mallinckrodt
Johnson and Johnson
Harvard Business School
Moodys

Last Updated: December 6, 2022

CLINICAL TRIALS PROFILE FOR VIGAMOX


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Vigamox

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00312338 ↗ Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora Completed Tufts University Phase 4 2006-06-01 Topical Treatment of Bacterial Conjunctivitis and its Effect on Microbial Flora
NCT00312338 ↗ Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora Completed Alcon Research Phase 4 2006-06-01 Topical Treatment of Bacterial Conjunctivitis and its Effect on Microbial Flora
NCT00324168 ↗ Steroids for Corneal Ulcers Trial Completed Aravind Eye Hospitals, India Phase 4 2006-09-01 The purpose of this study is to determine whether adding topical steroids improves the outcomes of bacterial corneal ulcers, especially visual acuity.
NCT00324168 ↗ Steroids for Corneal Ulcers Trial Completed Dartmouth-Hitchcock Medical Center Phase 4 2006-09-01 The purpose of this study is to determine whether adding topical steroids improves the outcomes of bacterial corneal ulcers, especially visual acuity.
NCT00324168 ↗ Steroids for Corneal Ulcers Trial Completed National Eye Institute (NEI) Phase 4 2006-09-01 The purpose of this study is to determine whether adding topical steroids improves the outcomes of bacterial corneal ulcers, especially visual acuity.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Vigamox

Condition Name

Condition Name for Vigamox
Intervention Trials
Cataract Extraction 4
Bacterial Conjunctivitis 4
Endophthalmitis 4
Eye Infections 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Vigamox
Intervention Trials
Cataract 9
Eye Infections 5
Endophthalmitis 5
Conjunctivitis, Bacterial 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Vigamox

Trials by Country

Trials by Country for Vigamox
Location Trials
United States 32
Brazil 4
Israel 2
Egypt 2
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Vigamox
Location Trials
Missouri 5
New York 4
California 3
Texas 3
Pennsylvania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Vigamox

Clinical Trial Phase

Clinical Trial Phase for Vigamox
Clinical Trial Phase Trials
Phase 4 15
Phase 3 4
Phase 2 4
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Vigamox
Clinical Trial Phase Trials
Completed 21
Recruiting 4
Terminated 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Vigamox

Sponsor Name

Sponsor Name for Vigamox
Sponsor Trials
Alcon Research 5
Bausch & Lomb Incorporated 3
Merck Sharp & Dohme Corp. 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Vigamox
Sponsor Trials
Other 31
Industry 16
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
AstraZeneca
McKinsey
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.